Authors:
Castelo-Branco, C
Pons, F
Vicente, JJ
Sanjuan, A
Vanrell, JA
Citation: C. Castelo-branco et al., Preventing postmenopausal bone loss with ossein-hydroxyapatite compounds -Results of a two-year, prospective trial, J REPRO MED, 44(7), 1999, pp. 601-605
Authors:
Castelo-Branco, C
de Osaba, MJM
Pons, F
Casals, E
Sanjuan, A
Vicente, JJ
Vanrell, JA
Citation: C. Castelo-branco et al., Ossein-hydroxyapatite compounds for preventing postmenopausal bone loss - Coadjuvant use with hormone replacement therapy, J REPRO MED, 44(3), 1999, pp. 241-246
Authors:
Alvarez, L
Oriola, J
Jo, J
Ferro, T
Pons, F
Peris, P
Guanabens, N
Duran, M
Monegal, A
de Osaba, MJM
Rivera-Fillat, F
Ballesta, AM
Citation: L. Alvarez et al., Collagen type I alpha 1 gene Sp1 polymorphism in premenopausal women with primary osteoporosis: Improved detection of Sp1 binding site polymorphism in the collagen type 1 gene., CLIN CHEM, 45(6), 1999, pp. 904-906
Authors:
Gratacos, J
Collado, A
Pons, F
Osaba, M
Sanmarti, R
Roque, M
Larrosa, M
Munoz-Gomez, J
Citation: J. Gratacos et al., Significant loss of bone mass in patients with early, active ankylosing spondylitis - A followup study, ARTH RHEUM, 42(11), 1999, pp. 2319-2324